Podcast Episode: JACC: CardioOncology Pulse – The PROACT Trial: Findings and Key Takeaways
JACC: CardioOncology Editor-in-chief, Bo nnie Ky, MD, MSCE, FACC and David Austin, MD, FRCP discuss PROACT, a phase three randomized open label blinded endpoint superiority trial of enalapril to prevent anthracycline induced cardiotoxicity. Speaker(s): Bonnie Ky, David Austin Your browser does not support the audio element. J Am Coll Cardiol CardioOnc. 2022 Mar, 4 (1) 19-37 J Am Coll Cardiol CardioOnc. 2023 Jun, 5 (3)